Epilepszia: vizsgálatok itt: Ausztria
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Where
- Innsbruck, Linz, Salzburg, Vienna
- Életkor
- 12 év and over
- People
- 160 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05667142 · EU 2022-502286-16-00 - 3. fázisTaking peopleA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Where
- Innsbruck, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 360 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00 - 3. fázisCsak meghívásosAn Open-label Study of XEN1101 in Epilepsy
- Where
- Innsbruck, Linz, Salzburg, Vienna
- Életkor
- 12 év and over
- People
- 880 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00 - No phaseCsak meghívásos5-SENSE Score Validation Study
- Where
- Salzburg
- Életkor
- 15 év and over
- People
- 400 worldwide
- Run by
- Duke University
See details and how to joinNCT06138808 - 2. fázisCsak meghívásosLong-term Safety and Tolerability of BHV-7000
- Where
- Linz, Salzburg, St. Poelten, Vienna
- Életkor
- 18 év to 75 év
- People
- 660 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00 - 2. fázisTaking peopleEpiflux
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 60
- Run by
- Medical University Of Vienna
See details and how to join2024-515540-23-00 · EU 2024-515540-23-00